chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Right hand and arm up to shoulder has tingling and feeling of pins poking, started to feel in left hand & arm; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FC3182) via an unspecified route of administration in the right arm on 27Aug2021 at 18:00 (at the age of 46-year-old) as a single dose for COVID-19 immunisation. Medical history included methicillin-susceptible staphylococcus aureus sepsis (MSSA). The patient had known allergy to antihistamines. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included buspirone (MANUFACTURER UNKNOWN) and ALIVE WOMEN'S MULTI VITAMIN both for unknown indication from an unknown date and unknown if ongoing . The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: FC3180), via an unspecified route of administration in the right arm on 09Aug2021 at 12:15 (at the age of 46-year-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Aug2021 at 06:00 the patient experienced tingling in right hand and arm up to shoulder and feeling of pins poking which had started 2 days after injection. On 30Aug2021 patient started to feel in left hand & arm too and seemed to be getting worse. It was happening at least a dozen times day. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event tingling in right hand and arm up to shoulder, feeling of pins poking and started to feel in left hand & arm too was not recovered at the time of this report.
Tinnitus since first dose, similar to feel I have after driving long distances; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the arm left on an unknown date in Mar2021 at 09:00 (at the age of 51-year-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the arm left on 22Apr2021 at 09:00 (at the age of 51-year-old) as a single dose for COVID-19 immunisation. Medical history included high cholesterol, high uric acid and penicillin allergy. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. The patient previously took codeine (MANUFACTURER UNKNOWN) for unknown indication on an unknown date and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Mar2021, the patient experienced tinnitus since first dose which was similar what patient experienced after driving long distances. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event tinnitus since first dose which was similar to the patient had after driving long distances was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
lost muscle movement in his left eye; This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP) from a sales representative.  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: EXTRAOCULAR MUSCLE DISORDER (non-serious), outcome "unknown", described as "lost muscle movement in his left eye".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from a 49 year old female with seasonal allergy who on 01-JUL-2008 was vaccinated with an unspecified dose of GARDASIL. Concomitant therapy included SYNTHROID and unspecified allergy medications. On 02-JUl-2008, the patient experienced pain and soreness at the injection site and flu like symptoms. The patient did not seek medical attention. About 3 weeks after receiving shots, on approximately 22-JUL-2008, the patient recovered. Additional information has been requested.
Patient was given Moderna for booster, correct booster for age should have been Pfizer.
10 minutes after receiving vaccine patient complained for being jittery and having an elevated heart rate.   monitored BP, heart rate and 02 saturation; patient chose to leave with her friend and drive to Medical Center for evaluation
pateint was given the Hep A (adult) 1 single dose of the vaccine 50u/1-mL syringe by the Medical Assistant.  Doctor had ordered the Hep A (ped/adol) dose of the vaccine 25u/0.5mL syringe.  Wrong dosage was given.  Parent was notified the following morning when error was discovered by myself, site supervisor of health facility.  Parent stated patient has not had any side effects or symptoms from the vaccines given on 2/16/2021.  Parent will monitor patient for symptoms.
SOME CHILLS; SLIGHT FEVER; EXHAUSTED; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the subject experienced some chills, slight fever, and exhausted. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the slight fever, some chills and exhausted was not reported. This report was non-serious.
(during the night of sleep only) Fever, violent shaking, head ache, charlie horse in calves; (daytime) achy, sore joints, head ache, fever
dizziness; fatigue; weakness; This is a spontaneous report from a contactable consumer (patient). A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as 2nd dose, single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient received first dose of BNT162B2 on an unspecified date for covid-19 immunisation. On an unspecified date, the patient experienced dizziness, fatigue, and weakness. The report received as, the patient states he got the second dose of the Pfizer COVID-19 vaccine two weeks ago and wants to know how long his side effects of dizziness, fatigue, and weakness will last. The patient called his doctor, and they told the patient to wait a couple of weeks. Outcome of the events was unknown.  Information about batch/ lot number has been requested.
Fever 101, fatigue, BP 171/89, major headache, dizziness, weakness, heart rate 95, unable to catch breath.
Information has been received from a registered nurse concerning a 10 year old white female with no known allergies or pertinent medical history who on 28-NOV-1997 was vaccinated with a first dose of varicella virus vaccine live (Oka/Merck). The patient had a fever and nasal congestion at the time of vaccination. On 28-MAY-2007 the patient developed a rash, nasal congestion, a cough and fever two days in duration. The patient was exposed to varicella and developed varicella lesions head to toe. It was unspecified if medical attention was sought. There were no lab studies performed. On 05-JUN-2007 the patient recovered. No further information is expected.
Initial information received on 11-Dec-2018 regarding an unsolicited valid non-serious case received from a company via consumer/non-health care professional. This case involves a 62 years old female patient who experienced nasal drip, cold and cough, while she received vaccine FLUZONE QUADRIVALENT. The patient's past medical history, medical treatment(s), vaccination(s), concomitant medications and family history were not provided. On an unknown date, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B VACCINE (lot number, expiry date, dose, dose in series not reported) via unknown route in unknown administration site. On an unknown date, the patient developed a non-serious nasal drip, cold and cough following the administration of INFLUENZA QUADRIVAL A-B VACCINE. No lab data was reported. Final diagnosis was cough, cold and nasal drip. It was not reported if the patient received a corrective treatment. The patient outcome is reported as Unknown for cough, as Unknown for nasal drip and as Unknown for cold. List of document held: none.
Spontaneous cerebral infarct suspected to be from venous thrombosis complicated by intracranial hemorrhage requiring intubation, EVD placement and emergent OR. Admitted to Neuro ICU
Initial report was received from a nurse on 04 Dec 2009: This patient (age less than 04 years) inadvertently received a FLUVIRIN 0.5 ml, intramuscular on 04 Dec 2009. No adverse events were reported.
got dizzy and almost passed out; got dizzy and almost passed out; had slight pain at injection site/awoke with moderate pain (5/10); This is a spontaneous report from a contactable consumer (patient). A 68-year-old female patient (no pregnancy) received the first dose of BNT162B2 (Pfizer-BIONTECH Covid-19 Vaccine, lot number: EL9262), via an unspecified route of administration at the site of left arm at 12:45 on 28Jan2021 at single dose for COVID-19 immunisation. Medical history reported as none. There were no concomitant medications. Clinical course: patient was vaccinated about 12:45 pm with no ill effects. When she went to bed, she had slight pain at injection site. She awoke with moderate pain (5/10) about 1 am. She got up to get some paracetamol (TYLENOL). On the way to the kitchen, she got dizzy and almost passed out. She found a chair and rested. She went back to bed (with no paracetamol). No other problems. No other vaccine received in four weeks. No other medications received in two weeks. No treatment received for adverse event. No covid prior vaccination. No covid tested post vaccination. No known allergies. Adverse reactions did not result any serious consequences. The outcome of events was recovered on an unspecified date.
1 st dose Moderna 01/28/2021- no lot #  Pt dies from heart failure complications in the hospital  Did not die from Covid 19
erythema, edema lt upper arm, breast;uncertain if cellulitis also started ATB;
A report had been received from a literature source via regulatory authority, vaccine adverse event reporting system (VAERS) concerning an adult, female subject, enrolled in a study. FLUMIST (intranasal) was administered on an unknown date. It was reported that after receiving QLAIV3 there was spontaneous abortion. The outcome of the event of drug exposure during pregnancy and spontaneous abortion was unknown. Assessment of the serious criteria for the report was as follows: Important medical event. The company physician considered the causality between suspect drug FLUMIST with the events of drug exposure during pregnancy and spontaneous abortion to be No.
side effects/symptoms; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by another health care professional and describes the occurrence of VACCINATION COMPLICATION (side effects/symptoms) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (side effects/symptoms). At the time of the report, VACCINATION COMPLICATION (side effects/symptoms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant drugs were not reported. Treatment medications were not provided.
Earlier felt slight itch at injection site.  Now have red rash extending down arm, across back, and patches elsewhere on body.  Very itchy.
My heart feels like it is floating in fluid or slightly swollen; My heart feels like it is floating in fluid or slightly swollen; Energy levels are much lower than normal; 1st dose, 17May2021; 2nd dose, 12Aug2021; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 37-year-old male patient received second dose of bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot number: UNKNOWN), via an unspecified route of administration in arm right on 12Aug2021 at 11:30 (at the age of 37-years-old) as dose 2, single for covid-19 immunisation. The medical history of the patient included COVID-19 from an unknown date and unknown if ongoing. The patient was allergic to penicillin and Amoxicillin. The concomitant medications of the patient were not reported. The patient previously took first dose of bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot number: UNKNOWN), via an unspecified route of administration in arm right on 17May2021 at 16:00 (at the age of 37-years-old) as single dose for covid-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the covid vaccine. Prior to vaccination, the patient was diagnosed with covid-19. Since the vaccination, the patient not been tested with covid-19. On 14Aug2021 at 10:00, the patient experienced my heart feels like it is floating in fluid or slightly swollen, energy levels are much lower than normal. The reporter reported this report as non-serious. The patient underwent lab tests and procedures which included sars-cov-2 test: covid on an unspecified date. It was unknown if the patient received the treatment. The outcome of the events was reported as unknown.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.  This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
About 2 hours after receiving my vaccine, I went to bed. I woke up around 6AM to a burning sensation on my face. My face was bright red, swollen, and I could barely open my eyes. I had hives on my back and around my arms and chest area. I went to the urgent care. It seemed to improve, but was not completely gone. The rash started to get worse again. My face started swelling up with hives again. I went to my PCP to get another prescription for my rash. It wasn't clearing up, so a few days later I went back to the PCP. She saw it was getting worse so she put me on a higher dose. I also went to a dermatologist. He gave me a cream and told me not to take any more oral steroids. The cream she gave me was a steroid cream and that helped. It eventually went away. About 4 days after I stopped using the cream, it started to show up around my nose and on my cheeks next to my nose. It gets kind of a weird skin texture and gets red. It almost feels like a sunburn. When I put the cream on, it makes it go away over night. So now I just use the cream on an as needed basis. Every about 4-5 days it shows back up.
Hoarse voice, tremulous. Vitals were normal for entire time monitored. No stridor or wheezing occurred.  No hives noted. Pt was given 25mg diphenhydramine p.o. and famotidine 40mg p.o. Pt did well, was monitored for about 45min with frequent vitals and exam. Pt discharged home and instructed to take diphenhydramine every 6 hrs for the next 24hrs and to call '911' if serious sxs occur.
Soreness in arm for 2 days.  Redness in area.  Slight tightness in chest.  No medical treatment needed.  Patient did not report reaction till reported for titer.  patient has referred titer.
Moderna vaccine was administered to a patient as a booster dose past the published expiry date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna vaccine was administered to a patient as a booster dose past the published expiry date) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012H21B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 16-Jun-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jun-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna vaccine was administered to a patient as a booster dose past the published expiry date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna vaccine was administered to a patient as a booster dose past the published expiry date) outcome was unknown.    For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No adverse events were reported.   This case was linked to MOD-2022-590722, MOD-2021-307110 (Patient Link).
The pt developed a 4cm area of warm, tender, red and swelling around the site of the vaccinia vaccine. It was treated with Levaquin 500mg X 5 days.
This initial non-serious spontaneous case, was received on 01-Nov-2017, from a physician, concerning adult male patient of unspecified age. This refers to 83rd out of 84 patients. On an unspecified date in Oct-2017 (between 25-Oct-17 to 27-Oct-17), the patient was administered with AFLURIA (TIV) Thiomersal (batch number: 14649211A, dose, route of administration, anatomical location and expiry date: not reported). It was reported that, the vaccine was stored in cooler with ice packs for 6 days and had reached unknown temperature during transport instead of storing at 36-degree F and 46-degree F (2-degree C and 8-degree C). And the same was administered to the patient. The reporter stated that the temperature was not monitored on 24-Oct-2017 (could have been between 2-8C, but not certain) and there were no reports of adverse effect after vaccination. The vaccine had been discarded. Follow up received on 09-Nov-2017 from a physician: Added event (no adverse effect) and reporter's comment. Amended narrative accordingly.
it was like kind of hard to breathe sometimes; Sore body; This case was reported by a consumer via patient support programs and described the occurrence of general body pain in a 64-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced general body pain and difficulty breathing. On an unknown date, the outcome of the general body pain was recovered/resolved and the outcome of the difficulty breathing was unknown.   It was unknown if the reporter considered the general body pain and difficulty breathing to be related to Shingrix.  Additional details were provided as follows: Patient received Shingrix dose on an unknown date. Age was not reported. Shingrix shot caused him to be sore for 2 weeks.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021073236:Pharma case
Information has been received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's healthcare providers recommended and/or prescribed ZOSTAVAX to the patient to obtain permanent prevention of shingles and zoster-related injuries. On or about 14-NOV-2007, a physician administered the ZOSTAVAX to the patient (lot number, dosage and route of administration not provided). On or about 10-MAR-2016, the patient was treated by a physician for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the zoster vaccine live (ZOSTAVAX), and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was considered to be not recovered. Additional information has been requested.
No adverse reaction report. Dr spoke with patient and explained theoretical side effects of administering live vaccines during pregnancy. Patient follow up with O.B. on 3/13/23, 3/10/23. Next appt 4/6/23.
Circular raised red rash on right side of midline on chest just below sternum. No itching. Seems the same two days later.
Pt stated experiencing the onset of itching in her left arm and face after receiving the Covid vaccine in her left arm.  Pt also stated experiencing a mild episode of feeling light headed after the administration of Covid vaccine.  No Redness, Swelling, or Rash at injection site or on face.  25mg Benedryl administered p.o. at 9:21am.
Chest pain and exertional dyspnea started 2-3 days post-vaccination.  NSAIDS, rest, omeprazole did not help. Examine and auscultation at infirmary following week- normal, per clinician . Central chest pain  frequency and intensity increased in following days,  spent 8 hours at hospital emergency room, thorough workup/ open diagnosis "non-specific inflammation" and referred to cardiologist.  3/2822 cardiologist visit, 4/11/22 echocardiogram, follow up week or two later.  Still, 7 months later, having chest pain with exertion, but has lessened. Less episodes of pain when at rest. Still some exertional shortness of breath. Of note, Patient is a standout athlete,  played 4 sports in high school , has been on volleyball club and cross country teams, avid long distance runner, and had NEVER had ANY episodes of chest pain or shortness of breath prior to receiving  the COVID vaccine.
Nausea, Muscle aches, chills slight headache.  Treated with soda and crackers, ibuprofen.